Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis

A prime–boost strategy of COVID-19 vaccines brings hope to limit the spread of SARS-CoV-2, while the immunogenicity of the vaccines is waning over time. Whether a booster dose of vaccine is needed has become a widely controversial issue. However, no published meta-analysis has focused on the issue....

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Haoyue, Peng, Zhicheng, Si, Shuting, Alifu, Xialidan, Zhou, Haibo, Chi, Peihan, Zhuang, Yan, Mo, Minjia, Yu, Yunxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142990/
https://www.ncbi.nlm.nih.gov/pubmed/35632554
http://dx.doi.org/10.3390/vaccines10050798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142990/
https://www.ncbi.nlm.nih.gov/pubmed/35632554
http://dx.doi.org/10.3390/vaccines10050798

Ejemplares similares